Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Regeneron Pharmaceuticals, Inc. REGN

Healthcare  —  Biotechnology
788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) Price to free cash flow

As of 25 September 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at a price to free cash flow of 22.7×. Over the past ten years it has ranged from 0.0× (September 2015) to 257× (June 2015); the current reading is higher than 37% of that period. That is above the Biotechnology industry median of 21.2× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 21.4× (0.71%)
FY2024 21.6× (17.98%)
FY2023 26.3× 15.94%
FY2022 22.7× 122.12%
FY2021 10.2× (60.60%)
FY2020 25.9× 26.58%
FY2019 20.5× (7.84%)
FY2018 22.2× (43.43%)
FY2017 39.3× (3.68%)
FY2016 40.8× (52.37%)

Quarterly

Period Price to free cash flow Change
Jun 2026 17.9× (15.41%)
Mar 2026 21.2× (1.15%)
Dec 2025 21.4× 42.87%
Sep 2025 15.0× (3.26%)
42 more quarters

Against its own ten years

Low 0.0× High 257×
Ten-year median 25.8×
Current reading's percentile 37

Price to free cash flow against peers

Company Price to free cash flow
INSM Insmed, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
MRNA Moderna, Inc. compare n/m
RPRX Royalty Pharma PLC compare 19.8×
REGN Regeneron Pharmaceuticals, Inc. 22.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 30.7×
VRTX Vertex Pharmaceuticals Incorporated compare 35.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 41.7×
ARGX argenex SE compare 43.4×
Biotechnology industry median 21.2×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on REGN